NCT01163396View on ClinicalTrials.gov

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2010

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

Bevacizumab

DRUG

Irinotecan

DRUG

Oxaliplatin

DRUG

5-fluorouracil/leucovorin

All Listed Sponsors
lead

Gruppo Oncologico del Nord-Ovest

OTHER

NCT01163396 - First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter